Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Antithrombotic agents in stroke indications

Feb. 2, 1998

FDA advisory committee recommends Integrilin approval

Jan. 29, 1998

Clinical development of LM-AS-013 advances at Green Cross

Jan. 29, 1998

Additional data submitted to FDA to support Novastan NDA

Jan. 26, 1998

Ortho reveals new fibrinogen receptor antagonists

Jan. 26, 1998

Lilly prepares compounds for controlling TxA2

Jan. 23, 1998

Boehringer Ingelheim develops new antiplatelet agents

Jan. 21, 1998

Lovenox/Clexane receives approvals in 11 additional countries

Jan. 20, 1998

DuPont Merck develops new factor Xa inhibitors as anticoagulants

Jan. 16, 1998

Oral heparin preparation completes additional phase I trials

Jan. 16, 1998

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.